The California Assembly Committee on Environmental Safety and Toxic Materials voted yes to proposed AB 495 at a 14 January hearing in Sacramento. As drafted, the bill continues to face industry opposition, but its author and cosponsors have committed to changes that would align the legislation more closely with EU regulations and potentially resolve industry’s biggest concerns.

Minnesota Democrat Collin Peterson’s bill, the first targeting FDA’s CBD question, could provide an entire answer or it could set table for discussion in Congress about legislation on establishing an FDA regulation on using CBD, and potentially other hemp-derived substances, in products other than drugs subject to its oversight.

Recommendations from an FDA-led interagency work group regarding methods for detecting and measuring asbestos in talc and talc-containing cosmetics will be presented at the agency’s planned public meeting in Silver Spring, MD, on 4 February. The recommendations are summarized in the FDA's meeting notice, which follows contentious cosmetic product recalls based on asbestos findings.

The opportunity represented by cannabidiol, and the uncertain future for commonly used sunscreen active ingredients in the US and microplastic in the EU, were issues of high interest among cosmetics industry stakeholders in 2019.

The European Chemicals Agency will implement an updated completeness check process in April for dossiers submitted under REACH. The revised check will extend to chemical safety reports, the agency says, noting that dossiers previously submitted successfully may not pass muster now.

The California Assembly Committee on Environmental Safety and Toxic Materials voted yes to proposed AB 495 at a 14 January hearing in Sacramento. As drafted, the bill continues to face industry opposition, but its author and cosponsors have committed to changes that would align the legislation more closely with EU regulations and potentially resolve industry’s biggest concerns.

Minnesota Democrat Collin Peterson’s bill, the first targeting FDA’s CBD question, could provide an entire answer or it could set table for discussion in Congress about legislation on establishing an FDA regulation on using CBD, and potentially other hemp-derived substances, in products other than drugs subject to its oversight.

Cosmetic products in California that contain at least one of more than a dozen listed ingredients or contaminants – or any others selected by the health department going forward – would be adulterated and thus unlawfully marketed under the proposed Toxic-Free Cosmetics Act.

Cosmetics regulatory reform efforts continued in 2019, which also saw Congress’s first cosmetics safety hearing since 2016. Meanwhile, the “clean” beauty movement gained momentum, fueled by the widely held perception that outdated regulations are allowing cosmetics consumers to be exposed to dangerous chemicals.

Suspected trace carcinogen 1,4-dioxane must be limited to 2 parts per million in personal cleansing products sold in New York after 31 December 2022, and 1 ppm one year later, under recently enacted legislation. More cosmetics news in brief.

Tom's natural claims on toothpastes and deodorants are false and misleading, a plaintiff alleges in a proposed class action filed in Massachusetts federal court. Similar to previous complaints against Colgate/Tom’s, the plaintiff’s case is premised on the contention that “natural,” as opposed to “100% natural,” means no synthetic ingredients.

The iconic sunscreen brand aims to capitalize on growing demand for mineral sunscreens – widely perceived as consumers’ safest option in sun defense – by positioning offerings that contain mixes of mineral and chemical UV filters as “mineral-based,” according to a suit filed in December in California federal court.

California federal courts have shown themselves receptive to proposed class actions alleging that purported cosmetics carrying unapproved drug claims violate the state’s Unfair Competition Law. Plaintiffs now are testing similar theories in suits against marketers of CBD-infused topical products.

Tarte admits no wrongdoing in its settlement with nationwide purchasers of its “high performance naturals,” and it put up little fight in order to minimize costs. Insight remains limited as to whether federal courts agree with plaintiffs that general “natural” claims on cosmetic products – as opposed to “all natural” or “100% natural” assertions – mean no synthetic ingredients at all.

US lawmakers and even two FTC commissioners are critical of the agency’s proposed settlement with skin-care marketer Sunday Riley, which allegedly misled consumers for almost two years with sham product reviews posted to Sephora.com. According to Venable partner Alexandra Megaris, the company isn’t exactly getting off easy, and broader industry compliance is likely to improve as a result.

Eighteen plaintiffs seeking nationwide class certification may proceed with their suit alleging that Monat hair-care products, deceptively advertised as anti-aging solutions, actually cause hair loss. A US district judge on 23 October largely denied Monat’s motion to dismiss, while noting that plaintiffs may have difficulty proving that the company’s products are to blame for their injuries.